NCT02398045

Brief Summary

The study aims to pilot a new computerised cognitive behavioural therapy programme for a small case series of adults with obsessive-compulsive disorder. The investigators hypothesise that the findings will demonstrate improvements in symptomatology following the programme. The programme will have longer-term aims of being rolled out over a number of IAPT services within the NHS, reducing waiting lists and increasing therapist time.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at P25-P50 for early_phase_1

Timeline
Completed

Started Oct 2015

Typical duration for early_phase_1

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2014

Completed
10 months until next milestone

First Posted

Study publicly available on registry

March 25, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

August 30, 2016

Status Verified

February 1, 2016

Enrollment Period

2 years

First QC Date

June 4, 2014

Last Update Submit

August 29, 2016

Conditions

Keywords

Obsessive-compulsive disordercognitive behavioural therapycomputerised

Outcome Measures

Primary Outcomes (1)

  • Change in Y-BOCS-OCD

    Yale-Brown Obsessive-Compulsive Scale for OCD. Questions focus on obsessive thoughts participants may have along with behaviours they feel compelled to do in order to reduce their anxiety. This outcome is expected to change (improve) from baseline throughout the trial as a result of the computerised CBT.

    baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up

Secondary Outcomes (8)

  • Psychiatric Diagnostic Screening Questionnaire

    baseline

  • DSM-IV OCD SCID

    baseline

  • Patient Health Questionnaire

    baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up

  • Generalised anxiety disorder assessment

    baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up

  • Work and social adjustment scale

    baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up

  • +3 more secondary outcomes

Study Arms (1)

Computerised CBT

EXPERIMENTAL

Computerised CBT for OCD

Other: Computerised CBT for OCD

Interventions

Computerised CBT for OCD

Computerised CBT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 or over with OCD as defined by DSM-IV who are seeking CBT.
  • The patient describes their OCD as their main problem and scores between 14 and 30 on the YBOCS (Goodman et al, 1989). A score above 30 is in the severe range and indicates that the CBT should probably be therapist delivered.
  • Able to use self-help materials in English and answer written questionnaires.
  • Able to access the internet (either at home or in a public library or drop in centre or at the clinic).
  • Have a current episode of OCD of more than 6 months in duration.

You may not qualify if:

  • Significant and complex co-morbidity (e.g. significant personality disorder, severe depression or alcohol dependence, which requires longer therapy or is more difficult to treat). Such patients are likely to be part of a Community Mental Health team or be funded by the Department of Health's National Specialist Commissioning Team scheme for severe treatment refectory OCD.
  • Current active suicidal intent or severe self-neglect that requires hospitalisation.
  • The patient has a primary problem of compulsive hoarding (as such patients are more complex or are more likely to be under a Community Mental Health team).
  • Continuing to receive another form of psychotherapy.
  • Has received CBT for OCD in the past year.
  • A participant may be taking an anti-depressant for OCD but must be on a stable dose for at least 12 weeks prior to entry in the trial with no plans to alter the dose during the trial period. There must also be no plan to commence on an anti-depressant or anti-psychotic medication. (Participants excluded because of their current or planned medication may be offered a further assessment for the trial after being on a stable dose

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre for Anxiety Disorders and Trauma

London, London, SE5 8AZ, United Kingdom

RECRUITING

South London and Maudsley NHS Trust

London, SE5 8AZ, United Kingdom

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • David Veale, MRCPsych

    Institute of Psychiatry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Veale, MRCPsych

CONTACT

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

June 4, 2014

First Posted

March 25, 2015

Study Start

October 1, 2015

Primary Completion

October 1, 2017

Study Completion

December 1, 2017

Last Updated

August 30, 2016

Record last verified: 2016-02

Locations